Skip to main content

Advertisement

Log in

Frequency of Genetic and Epigenetic Alterations of p14ARF and p16INK4A in Head and Neck Cancer in a Hungarian Population

  • Research
  • Published:
Pathology & Oncology Research

Abstract

Occurrence of genetic and epigenetic alterations affecting p14ARF and p16INK4A were investigated in tumour samples of 37 oral (OSCC) and 28 laryngeal squamous cell cancer (LSCC) patients, and compared to exfoliated buccal epithelial cells of 68 healthy controls. Presence of deletions and mutations/polymorphisms affecting exons were examined using sequencing. Methylation status of promoters was assessed by methylation-specific PCR. Chi-square and Fisher’s exact tests were used to compare frequency of events. Exon deletions were found in four controls, one OSCC and 22 LSCC patients; the latter significantly differed from controls (p < 0.001). Only two mutations (T24610A and C24702A) were in p16 exon 1 of two OSCC patients. Polymorphisms G28575A (Ala140Thr), G31292C (C540G) and G28608A were found in both patient groups. The p14 promoter was unmethylated in 86.7 % of OSCC and in 85.7 % of LSCC patients; for the p16 promoter these rates were 69.0 % and 76.2 % for OSCC and LSCC patients, respectively. Combining the two patient groups, unmethylated promoter was significantly less frequent in case of both p14 and p16 (p = 0.043 and p = 0.001, respectively) compared to the control group. In summary, exon deletion may be important in LSCC, while promoter methylation was relatively frequent in both patient groups.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global Cancer Statistics, 2002. CA Cancer J Clin 55:74–108

    Article  PubMed  Google Scholar 

  2. Calmon MF, Colombo J, Carvalho F, Souza FP, Filho JF et al (2007) Methylation Profile of Genes CDKN2A (p14 and p16), DAPK1, CDH1, and ADAM23 in Head and Neck Cancer. Cancer Genet Cytogenet 173:31–37

    Article  PubMed  CAS  Google Scholar 

  3. Demokan S, Dalay N (2011) Role of DNA Methylation in Head and Neck Cancer. Clin Epigenet 2:123–150

    Article  CAS  Google Scholar 

  4. Warnakulasuriya S, Sutherland G, Scully C (2005) Tobacco, Oral Cancer, and Treatment of Dependence. Oral Oncol 41:244–260

    Article  PubMed  Google Scholar 

  5. Freedman ND, Abnet CC, Leitzmann MF, Hollenbeck AR, Schatzkin A (2007) Prospective Investigation of the Cigarette Smoking-Head and Neck Cancer Association by Sex. Cancer 110:1593–1601

    Article  PubMed  Google Scholar 

  6. Curado MP, Hashibe M (2009) Recent Changes in the Epidemiology of Head and Neck Cancer. Curr Opin Oncol 21:195–200

    Article  Google Scholar 

  7. Ščėsnaitė A, Gudlevičienė Ž, Jarmalaitė S (2008) Promoter Hypermethylation of Tumour Suppressor Genes in Tumour Cells from Patients with Head and Neck Cancer. Biologija 54:161–166

    Article  Google Scholar 

  8. Andrews E, Seaman WT, Webster-Cyriaque J (2009) Oropharyngeal Carcinoma in non-Smokers and non-Drinkers: A Role for HPV. Oral Oncol 45:486–491

    Article  PubMed  Google Scholar 

  9. Sand LP, Jalouli J, Larsson PA, Hirsch JM (2002) Prevalence of Epstein-Barr Virus in Oral Cell Carcinoma, Oral Lichen Planus, and Normal Oral Mucosa. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93:586–592

    Article  PubMed  Google Scholar 

  10. Shimakage M, Horii K, Tempaku A, Kakudo K, Shirasaka T et al (2002) Association of Epstein-Barr Virus with Oral Cancers. Hum Pathol 33:608–614

    Article  PubMed  CAS  Google Scholar 

  11. Mao L, Hong WK, Papadimitrakopoulou VA (2004) Focus on Head and Neck Cancer. Cancer Cell 5:311–316

    Article  PubMed  CAS  Google Scholar 

  12. Hansson BG, Rosenquist K, Antonsson A, Wennerberg J, Schildt EB et al (2005) Strong Association Between Infection with Human Papillomavirus and Oral and Oropharyngeal Squamous Cell Carcinoma: A Population-Based Case–Control Study in Southern Sweden. Acta Otolaryngol 125:1337–1344

    Article  PubMed  Google Scholar 

  13. Kreimer AR, Clifford GM, Boyle P, Franceschi S (2005) Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review. Cancer Epidemiol Biomarkers Prev 14:467–475

    Article  PubMed  CAS  Google Scholar 

  14. Sherr CJ (2001) The INK4a/ARF Network in Tumour Suppression. Nat Rev Mol Cell Biol 2:731–737

    Article  PubMed  CAS  Google Scholar 

  15. Sharpless NE, DePinho RA (1999) The INK4A/ARF Locus and its two Gene Products. Curr Opin Genet Dev 9:22–30

    Article  PubMed  CAS  Google Scholar 

  16. Gallagher SJ, Kefford RF, Rizos H (2006) The ARF Tumour Suppressor. Int J Biochem Cell Biol 38:1637–1641

    Article  PubMed  CAS  Google Scholar 

  17. Belinsky SA, Nikula KJ, Palmisano WA, Mchels R, Saccomanno G et al (1998) Aberrant Methylation of p16INK4a in an Early Event in Lung Cancer and a Potential Biomarker for Early Diagnosis. Proc Natl Acad Sci 95:11891–11896

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  18. Shintani S, Nakahara Y, Mihara M, Ueyama Y, Matsumura T (2001) Inactivation of the p14ARF, p15INK4B and p16INK4A Genes is a Frequent Event in Human Oral Squamous Cell Carcinomas. Oral Oncol 37:498–504

    Article  PubMed  CAS  Google Scholar 

  19. Kim BN, Yamamoto H, Ikeda K, Damdinsuren B, Sugita Y et al (2005) Methylation and Expression of p16INK4 Tumor Suppressor Gene in Primary Colorectal Cancer Tissues. Int J Oncol 26:1217–1226

    PubMed  CAS  Google Scholar 

  20. Sailasree R, Abhilash A, Sathyan KM, Nalinakumari KR, Thomas S et al (2008) Differential Roles of p16INK4A and p14ARF Genes in Prognosis of Oral Carcinoma. Cancer Epidemiol Biomarkers Prev 17:414–420

    Article  PubMed  CAS  Google Scholar 

  21. Jaffrain-Rea ML, Ferretti E, Toniato E, Cannita K, Santoro A et al (1999) P16 (INK4a, MTS-1) Gene Polymorphism and Methylation Status in Human Pituitary Tumours. Clin Endocrinol 51:317–325

    Article  CAS  Google Scholar 

  22. Yan L, Na W, Shank K, Xiao-Wei M, Wei G et al (2008) P16 (CDKN2) Gene Polymorphism: Association with Histologic Subtypes of Epithelial Ovarian Cancer in China. Int J Gynecol Cancer 18:30–35

    Article  PubMed  CAS  Google Scholar 

  23. Thakur N, Hussain S, Nasare V, Das BC, Basir SF et al (2012) Association Analysis of p16 (CDKN2A) and RB1 Polymorphisms with Susceptibility to Cervical Cancer in Indian Population. Mol Biol Rep 39:407–414

    Article  PubMed  CAS  Google Scholar 

  24. Chen J, Li D, Wei C, Sen S, Killary AM et al (2007) Aurora-A and p16 Polymorphisms Contribute to an Earlier age at Diagnosis of Pancreatic Cancer in Caucasians. Clin Cancer Res 13:3100–3104

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  25. Chen J, Li D, Killary AM, Sen S, Amos CI et al (2009) Polymorphisms of p16, p27, p73, and MDM2 Modulate Response and Survival of Pancreatic Cancer Patients Treated with Preoperative Chemoradiation. Ann Surg Oncol 16:431–439

    Article  PubMed  Google Scholar 

  26. Sauroja I, Smeds J, Vlaykova T, Kumar R, Talve L et al (2000) Analysis of G1/S Checkpoint Regulators in Metastatic Melanoma. Genes Chromosomes Cancer 28:404–414

    Article  PubMed  CAS  Google Scholar 

  27. Zheng Y, Shen H, Sturgis EM, Wang LE, Shete S et al (2002) Haplotypes of two Variants in p16 (CDKN2/MTS-1/INK4a) Exon 3 and Risk of Squamous Cell Carcinoma of the Head and Neck: A Case–Control Study. Cancer Epidemiol Biomarkers Prev 11:640–645

    PubMed  CAS  Google Scholar 

  28. Kis A, Fehér E, Gáll T, Tar I, Boda R et al (2009) Epstein-Barr Virus Prevalence in Oral Squamous Cell Cancer and in Potentially Malignant Disorders in an Eastern Hungarian Population. Eur J Oral Sci 117:536–540

    Article  PubMed  CAS  Google Scholar 

  29. Szarka K, Tar I, Fehér E, Gáll T, Kis A et al (2009) Progressive Increase of Human Papillomavirus Carriage Rates in Potentially Malignant and Malignant Oral Disorders with Increasing Malignant Potential. Oral Microbiol Immunol 24:314–318

    Article  PubMed  CAS  Google Scholar 

  30. Baur AS, Shaw P, Burri N, Delacrétaz F, Bosman FT et al (1999) Frequent Methylation Silencing of p15INK4b (MTS2) and p16INK4a (MTS1) in B-Cell and T-Cell Lymphomas. Blood 94:1773–1781

    PubMed  CAS  Google Scholar 

  31. Chen TC, Hsieh LL, Kuo TT, Ng KF, Wu Chou YH et al (2000) P16 INK4 Gene Mutation and Allelic Loss of Chromosome 9p21-22 in Taiwanese Hepatocellular Carcinoma. Anticancer Res 20:1621–1626

    PubMed  CAS  Google Scholar 

  32. Nagy E, Beck Z, Kiss A, Csoma E, Telek B et al (2003) Frequent Methylation of p16INK4A and p14ARF Genes Implicated in the Evolution of Chronic Myeloid Leukaemia from its Chronic to Accelerated Phase. Eur J Cancer 39:2298–2305

    Article  PubMed  CAS  Google Scholar 

  33. Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB (1996) Methylation-Specific PCR: A Novel PCR Assay for Methylation Status of CpG Islands. Proc Natl Acad Sci 93:9821–9826

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  34. Ruesga MT, Acha-Sagredo A, Rodríguez MJ, Aguirregaviria JI, Videgain J et al (2007) P16INK4a Promoter Hypermethylation in Oral Scrapings of Oral Squamous Cell Carcinoma Risk Patients. Cancer Lett 250:140–145

    Article  PubMed  CAS  Google Scholar 

  35. Reed AL, Califano J, Cairns P, Westra WH, Jones RM et al (1996) High Frequency of p16 (CDKN2/MTS-1/INK4A) Inactivation in Head and Neck Squamous Cell Carcinoma. Cancer Res 56:3630–3633

    PubMed  CAS  Google Scholar 

  36. Nakahara Y, Shintani S, Mihara M, Ueyama Y, Matsumura T (2001) High Frequency of Homozygous Deletion and Methylation of p16INK4A Gene in Oral Squamous Cell Carcinomas. Cancer Lett 163:221–228

    Article  PubMed  CAS  Google Scholar 

  37. Bradley G, Irish J, MacMillan C, Mancer K, Witterick I et al (2001) Abnormalities of the ARF-p53 Pathway in Oral Squamous Cell Carcinoma. Oncogene 20:654–658

    Article  PubMed  CAS  Google Scholar 

  38. Lin SC, Chang KW, Chang CS, Liu TY, Tzeng YS et al (2000) Alterations of p16/MTS1 Gene in Oral Squamous Cell Carcinomas from Taiwanese. J oral Pathol Med 29:159–166

    Article  PubMed  CAS  Google Scholar 

  39. Ohta S, Uemura H, Matsui Y, Ishiguro H, Fujinami K et al (2009) Alterations of p16 and p14ARF Genes and Their 9p21 Locus in Oral Squamous Cell Carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107:81–91

    Article  PubMed  Google Scholar 

  40. Weber A, Bellmann U, Bootz F, Wittekind C, Tannapfel A (2002) INK4a-ARF Alterations and p53 Mutations in Primary and Consecutive Squamous Cell Carcinoma of the Head and Neck. Virchows Arch 441:133–142

    Article  PubMed  CAS  Google Scholar 

  41. Kulkarni V, Saranath D (2004) Concurrent Hypermethylation of Multiple Regulatory Genes in Chewing Tobacco Associated Oral Squamous Cell Carcinomas and Adjacent Normal Tissues. Oral Oncol 40:145–153

    Article  PubMed  CAS  Google Scholar 

  42. Salam I, Hussain S, Mir MM, Dar NA, Abdullah S et al (2009) Aberrant Promoter Methylation and Reduced Expression of p16 Gene in Esophageal Squamous Cell Carcinoma from Kashmir Valley: A High-Risk Area. Mol Cell Biochem 332:51–58

    Article  PubMed  CAS  Google Scholar 

  43. Hall GL, Shaw RJ, Field EA, Rogers SN, Sutton DN et al (2008) P16 Promoter Methylation is a Potential Predictor of Malignant Transformation in Oral Epithelial Dysplasia. Cancer Epidemiol Biomarkers Prev 17:2174–2179

    Article  PubMed  CAS  Google Scholar 

  44. Kondo Y, Shen L, Issa JP (2003) Critical Role of Histone Methylation in Tumor Suppressor Gene Silencing in Colorectal Cancer. Mol Cell Biol 23:206–215

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  45. Suzuki H, Maruyama R, Yamamoto E, Kai M (2013) Epigenetic Alteration and microRNA Dysregulation in Cancer. Front Genet 4:258

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The work was supported by National Scientific Research Fund (OTKA) F046749, Mecenatura Mec-13/2011 and TÁMOP-4.2.2/B-10/1-2010-0024 grants. The TÁMOP project is co-financed by the European Union and the European Social Fund. The funding sources had no role in study design, data collection and interpretation or writing of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Krisztina Szarka.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kis, A., Tatár, T.Z., Gáll, T. et al. Frequency of Genetic and Epigenetic Alterations of p14ARF and p16INK4A in Head and Neck Cancer in a Hungarian Population. Pathol. Oncol. Res. 20, 923–929 (2014). https://doi.org/10.1007/s12253-014-9775-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-014-9775-9

Keywords

Navigation